First Time Loading...

Goodrx Holdings Inc
NASDAQ:GDRX

Watchlist Manager
Goodrx Holdings Inc Logo
Goodrx Holdings Inc
NASDAQ:GDRX
Watchlist
Price: 6.69 USD 2.61% Market Closed
Updated: Apr 20, 2024

Intrinsic Value

GoodRx Holdings, Inc. operates a consumer-focused digital healthcare platform. [ Read More ]

The intrinsic value of one GDRX stock under the Base Case scenario is 8.76 USD. Compared to the current market price of 6.69 USD, Goodrx Holdings Inc is Undervalued by 24%.

Key Points:
GDRX Intrinsic Value
Base Case
8.76 USD
Undervaluation 24%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Goodrx Holdings Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling GDRX stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Goodrx Holdings Inc

Provide an overview of the primary business activities
of Goodrx Holdings Inc.

What unique competitive advantages
does Goodrx Holdings Inc hold over its rivals?

What risks and challenges
does Goodrx Holdings Inc face in the near future?

Has there been any significant insider trading activity
in Goodrx Holdings Inc recently?

Summarize the latest earnings call
of Goodrx Holdings Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Goodrx Holdings Inc.

Provide P/S
for Goodrx Holdings Inc.

Provide P/E
for Goodrx Holdings Inc.

Provide P/OCF
for Goodrx Holdings Inc.

Provide P/FCFE
for Goodrx Holdings Inc.

Provide P/B
for Goodrx Holdings Inc.

Provide EV/S
for Goodrx Holdings Inc.

Provide EV/GP
for Goodrx Holdings Inc.

Provide EV/EBITDA
for Goodrx Holdings Inc.

Provide EV/EBIT
for Goodrx Holdings Inc.

Provide EV/OCF
for Goodrx Holdings Inc.

Provide EV/FCFF
for Goodrx Holdings Inc.

Provide EV/IC
for Goodrx Holdings Inc.

Show me price targets
for Goodrx Holdings Inc made by professional analysts.

What are the Revenue projections
for Goodrx Holdings Inc?

How accurate were the past Revenue estimates
for Goodrx Holdings Inc?

What are the Net Income projections
for Goodrx Holdings Inc?

How accurate were the past Net Income estimates
for Goodrx Holdings Inc?

What are the EPS projections
for Goodrx Holdings Inc?

How accurate were the past EPS estimates
for Goodrx Holdings Inc?

What are the EBIT projections
for Goodrx Holdings Inc?

How accurate were the past EBIT estimates
for Goodrx Holdings Inc?

Compare the revenue forecasts
for Goodrx Holdings Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Goodrx Holdings Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Goodrx Holdings Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Goodrx Holdings Inc compared to its peers.

Compare the P/E ratios
of Goodrx Holdings Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Goodrx Holdings Inc with its peers.

Analyze the financial leverage
of Goodrx Holdings Inc compared to its main competitors.

Show all profitability ratios
for Goodrx Holdings Inc.

Provide ROE
for Goodrx Holdings Inc.

Provide ROA
for Goodrx Holdings Inc.

Provide ROIC
for Goodrx Holdings Inc.

Provide ROCE
for Goodrx Holdings Inc.

Provide Gross Margin
for Goodrx Holdings Inc.

Provide Operating Margin
for Goodrx Holdings Inc.

Provide Net Margin
for Goodrx Holdings Inc.

Provide FCF Margin
for Goodrx Holdings Inc.

Show all solvency ratios
for Goodrx Holdings Inc.

Provide D/E Ratio
for Goodrx Holdings Inc.

Provide D/A Ratio
for Goodrx Holdings Inc.

Provide Interest Coverage Ratio
for Goodrx Holdings Inc.

Provide Altman Z-Score Ratio
for Goodrx Holdings Inc.

Provide Quick Ratio
for Goodrx Holdings Inc.

Provide Current Ratio
for Goodrx Holdings Inc.

Provide Cash Ratio
for Goodrx Holdings Inc.

What is the historical Revenue growth
over the last 5 years for Goodrx Holdings Inc?

What is the historical Net Income growth
over the last 5 years for Goodrx Holdings Inc?

What is the current Free Cash Flow
of Goodrx Holdings Inc?

Financials

Balance Sheet Decomposition
Goodrx Holdings Inc

Current Assets 872.8m
Cash & Short-Term Investments 672.3m
Receivables 147.1m
Other Current Assets 53.3m
Non-Current Assets 716m
PP&E 45.9m
Intangibles 567.1m
Other Non-Current Assets 103m
Current Liabilities 122.6m
Accounts Payable 36.3m
Accrued Liabilities 70.4m
Other Current Liabilities 15.9m
Non-Current Liabilities 704.3m
Long-Term Debt 647.7m
Other Non-Current Liabilities 56.6m
Efficiency

Earnings Waterfall
Goodrx Holdings Inc

Revenue
750.3m USD
Cost of Revenue
-66.9m USD
Gross Profit
683.3m USD
Operating Expenses
-708.6m USD
Operating Income
-25.2m USD
Other Expenses
16.4m USD
Net Income
-8.9m USD

Free Cash Flow Analysis
Goodrx Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

GDRX Profitability Score
Profitability Due Diligence

Goodrx Holdings Inc's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

41/100
Profitability
Score

Goodrx Holdings Inc's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

GDRX Solvency Score
Solvency Due Diligence

Goodrx Holdings Inc's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
44/100
Solvency
Score

Goodrx Holdings Inc's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GDRX Price Targets Summary
Goodrx Holdings Inc

Wall Street analysts forecast GDRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GDRX is 8.94 USD with a low forecast of 5.05 USD and a high forecast of 14.7 USD.

Lowest
Price Target
5.05 USD
25% Downside
Average
Price Target
8.94 USD
34% Upside
Highest
Price Target
14.7 USD
120% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

GDRX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

GDRX Price
Goodrx Holdings Inc

1M 1M
-2%
6M 6M
+22%
1Y 1Y
+17%
3Y 3Y
-83%
5Y 5Y
-87%
10Y 10Y
-87%
Annual Price Range
6.69
52w Low
4.36
52w High
9.24
Price Metrics
Average Annual Return -41.7%
Standard Deviation of Annual Returns 37.99%
Max Drawdown -93%
Shares Statistics
Market Capitalization 2.6B USD
Shares Outstanding 403 248 000
Percentage of Shares Shorted 11.12%

GDRX Return Decomposition
Main factors of price return

What is price return decomposition?

GDRX News

Other Videos

Last Important Events
Goodrx Holdings Inc

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Goodrx Holdings Inc

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Goodrx Holdings Inc Logo
Goodrx Holdings Inc

Country

United States of America

Industry

Health Care

Market Cap

2.6B USD

Dividend Yield

0%

Description

GoodRx Holdings, Inc. operates a consumer-focused digital healthcare platform. The company is headquartered in Santa Monica, California and currently employs 756 full-time employees. The company went IPO on 2020-09-23. The firm provides GoodRx platform, which aggregates and analyzes pricing data from a number of different sources. Its platform also provides access to medication savings programs, medical provider consultations and lab tests through its telehealth offerings, GoodRx Care and the GoodRx Telehealth Marketplace, and other healthcare related content. Its prescription offering provides price comparisons and negotiated prices on prescriptions. Its subscription offerings provide consumers and their families with access to lower prescription prices on select medications in select pharmacies for a monthly or annual subscription fee. Its pharmaceutical manufacturer solutions offering provides advertising and integrated consumer affordability solutions to pharmaceutical manufacturers.

Contact

CALIFORNIA
Santa Monica
2701 Olympic Boulevard, Suite 990
+18552682822.0
https://investors.goodrx.com/

IPO

2020-09-23

Employees

756

Officers

Co-founder & Chairman
Mr. Trevor Bezdek
Co-founder, Chief Mission Officer & Director
Mr. Douglas Joseph Hirsch
CFO & Principal Financial Officer
Mr. Karsten Ian Voermann
Chief Accounting Officer & Principal Accounting Officer
Mr. Romin Nabiey
Interim CEO & Principal Operating Officer
Mr. Scott W. Wagner

See Also

Discover More
What is the Intrinsic Value of one GDRX stock?

The intrinsic value of one GDRX stock under the Base Case scenario is 8.76 USD.

Is GDRX stock undervalued or overvalued?

Compared to the current market price of 6.69 USD, Goodrx Holdings Inc is Undervalued by 24%.